|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0330 USD | -12.00% |
|
-15.38% | +26.92% |
| 19/05 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 17/11 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 0.0417 | 0.0417 | 0.2001 |
| Spread/Res. | -20.86% | -20.86% | -83.51% |
| Spread/Supp. | +120.00% | +2,100.00% | +2,100.00% |
| Support | 0.015 | 0.0015 | 0.0015 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ADAPY Stock
- Charts Adaptimmune Therapeutics plc
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
